Dudediligence.

GeoVax Labs, Inc

GOVXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.8MSep ’24$864,415Dec ’24$1.6MMar ’25$852,282Jun ’25$0.00Sep ’25$0.00Dec ’25$0.00Mar ’26$0.00Jun ’26
Net income, by quarter
−$5.8MSep ’24−$8.3MDec ’24−$5.4MMar ’25−$5.4MJun ’25−$6.3MSep ’25−$4.4MDec ’25−$5.3MMar ’26−$4.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$385,501$81,526$0.00$4.0M$2.5M
Operating income−$18.7M−$14.0M−$26.7M−$25.1M−$21.6M
Net income−$18.6M−$14.0M−$26.0M−$25.0M−$21.5M
Operating cash flow−$11.2M−$19.0M−$25.2M−$24.7M−$21.5M
Free cash flow−$11.2M−$19.2M−$25.2M−$24.7M−$21.5M
Cash$11.4M$27.6M$6.5M$5.5M$3.1M
Shares outstanding6.4M1.8M2.0M421.5K1.7M